# TILs for Treatment of Metastatic or Recurrent Cervical Cancer

> **NCT04674488** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai OriginCell Therapeutics Co., Ltd.** · enrollment: 15 (estimated)

## Conditions studied

- TILs, Metastatic or Recurrent Cervical Cancer

## Interventions

- **BIOLOGICAL:** TILs

## Key facts

- **NCT ID:** NCT04674488
- **Lead sponsor:** Shanghai OriginCell Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-09
- **Primary completion:** 2022-11-09
- **Final completion:** 2024-11-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674488, "TILs for Treatment of Metastatic or Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04674488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*